Surat, December 16, 2021: Anupam Rasayan (NSE, BSE: ANURAS), one of India’s leading custom synthesis & speciality chemical player, has signed long term binding contract worth Rs 1 35 crore with Japanese multinational customer for supplying an existing life science related speciality chemical. The company earlier signed LOI for this product with same customer and now have entered into a long-term contract for next four years.
Speaking about the order, Anand Desai, Managing Director of Anupam Rasayan, said, “We are delighted to inform you that we have signed yet another long-term binding contract with one of the top global chemical company. This conversion of LOI into a long-term contract reinforces the capability of our company to be a preferred partner with some of the world’s most marquee companies. We continue to work on expanding our chemistries and enhance the wallet share with our customers’
The speciality chemicals major is manufacturing products for over 66 domestic and international customers, including 23 multinational companies. The company has a long history of high customer retention and have been manufacturing products for select customers for over a decade. The company caters to a diverse base of Indian and global customers.
Corporate Comm India (CCI Newswire)
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…